In vitro selection of single-stranded DNA molecular recognition elements against S. Aureus alpha toxin and sensitive detection in human serum

International Journal of Molecular Sciences

Volumn 16, Issue 2, 2015, Pages 2794-2809

  Hong, Ka L ^a   Battistella, Luisa ^a   Salva, Alysia D ^a   Williams, Ryan M ^a,b   Sooter, Letha J ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Alpha toxin; Aptamer; ELISA; In vitro selection; Molecular recognition element (MRE); SELEX; SsDNA; Staphylococcus aureus

Indexed keywords

BOVINE SERUM ALBUMIN; CHOLERA TOXIN; CLOSTRIDIUM DIFFICILE TOXIN B; EXONUCLEASE; PSEUDOMONAS EXOTOXIN; SINGLE STRANDED DNA; STAPHYLOCOCCUS ALPHA TOXIN; BACTERIAL TOXIN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISSOCIATION CONSTANT; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IN VITRO SELECTION; LIMIT OF DETECTION; MOLECULAR CLONING; MOLECULAR RECOGNITION; NONHUMAN; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; SURFACE PLASMON RESONANCE; BLOOD; CHEMISTRY; CONFORMATION; KINETICS; METABOLISM; NUCLEOTIDE SEQUENCE; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

BACTERIAL TOXINS; BASE SEQUENCE; DNA, SINGLE-STRANDED; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KINETICS; NUCLEIC ACID CONFORMATION; SELEX APTAMER TECHNIQUE; STAPHYLOCOCCUS AUREUS; SURFACE PLASMON RESONANCE;

EID: 84921900792     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16022794     Document Type: Article

References (48)

1. Bhakdi, S.; Tranum-Jensen, J. Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 1991, 55, 733-751.
2. Lowy, F.D. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339, 520-532.
3. Mediavilla, J.R.; Chen, L.; Uhlemann, A.C.; Hanson, B.M.; Rosenthal, M.; Stanak, K.; Koll, B.; Fries, B.C.; Armellino, D.; Schilling, M.E., et al. Methicillin-susceptible Staphylococcus aureus ST398, New York and New Jersey, USA. Emerg. Infect. Dis. 2012, 18, 700-702
4. Vandenesch, F.; Naimi, T.; Enright, M.C.; Lina, G.; Nimmo, G.R.; Heffernan, H.; Liassine, N.; Bes, M.; Greenland, T.; Reverdy, M.E.; Etienne, J. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg. Infect. Dis. 2003, 9, 978-984.
5. Moet, G.J.; Jones, R.N.; Biedenbach, D.J.; Stilwell, M.G.; Fritsche, T.R. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn. Microbiol. Infect. Dis. 2007, 57, 7-13.
6. Stephens, J.M.; Gao, X.; Patel, D.A.; Verheggen, B.G.; Shelbaya, A.; Haider, S. Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: A comparison of linezolid, vancomycin, and daptomycin. Clinicoecon. Outcomes Res. 2013, 5, 447-457.
7. Vandenesch, F.; Lina, G.; Henry, T. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: A redundant arsenal of membrane-damaging virulence factors? Front. Cell. Infect. Microbiol. 2012, 2, 12.
8. Jacobsson, G.; Colque-Navarro, P.; Gustafsson, E.; Andersson, R.; Mollby, R. Antibody responses in patients with invasive Staphylococcus aureus infections. Eur. J. Clin. Microbiol. Infect. Dis. 2010, 29, 715-725.
9. Bubeck Wardenburg, J.; Patel, R.J.; Schneewind, O. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect. Immun. 2007, 75, 1040-1044.
10. Callegan, M.C.; Engel, L.S.; Hill, J.M.; O’Callaghan, R.J. Corneal virulence of Staphylococcus aureus: Roles of alpha-toxin and protein A in pathogenesis. Infect. Immun. 1994, 62, 2478-2482.
11. Kennedy, A.D.; Bubeck Wardenburg, J.; Gardner, D.J.; Long, D.; Whitney, A.R.; Braughton, K.R.; Schneewind, O.; DeLeo, F.R. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J. Infect. Dis. 2010, 202, 1050-1058.
12. Duckworth, G.J. Diagnosis and management of methicillin resistant Staphylococcus aureus infection. BMJ 1993, 307, 1049-1052.
13. Mitchell, D.H.; Howden, B.P. Diagnosis and management of Staphylococcus aureus bacteraemia. Intern. Med. J. 2005, 35, S17-S24.
14. Roberts, S.; Chambers, S. Diagnosis and management of Staphylococcus aureus infections of the skin and soft tissue. Intern. Med. J. 2005, 35, S97-S105.
15. Ramakrishna, U.S.; Kingston, J.J.; Harishchandra Sripathi, M.; Batra, H.V. Taguchi optimization of duplex PCR for simultaneous identification of Staphylococcus aureus and Clostridium perfringens alpha toxins. FEMS Microbiol. Lett. 2013, 340, 93-100.
16. Uppalapati, S.R.; Kingston, J.J.; Murali, H.S.; Batra, H.V. Generation and characterization of an inter-generic bivalent alpha domain fusion protein alphaCS from Clostridium perfringens and Staphylococcus aureus for concurrent diagnosis and therapeutic applications. J. Appl. Microbiol. 2012, 113, 448-458.
17. Reddy, P.K.; Shekar, A.; Kingston, J.J.; Sripathy, M.H.; Batra, H. Evaluation of IgY capture ELISA for sensitive detection of alpha hemolysin of Staphylococcus aureus without staphylococcal protein A interference. J. Immunol. Methods 2013, 391, 31-38.
18. Surujballi, O.P.; Fackrell, H.B. Enzyme-linked immunosorbent assay for detection of Staphylococcus aureus alpha-toxin. J. Clin. Microbiol. 1984, 19, 394-398.
19. Bordeaux, J.; Welsh, A.; Agarwal, S.; Killiam, E.; Baquero, M.; Hanna, J.; Anagnostou, V.; Rimm, D. Antibody validation. Biotechniques 2010, 48, 197-209.
20. Tuerk, C.; Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249, 505-510.
21. Williams, R.; Crihfield, C.; Gattu, S.; Holland, L.; Sooter, L. In vitro selection of a single-stranded DNA molecular recognition element against atrazine. Int. J. Mol. Sci. 2014, 15, 14332-14347.
22. Williams, R.M.; Kulick, A.R.; Yedlapalli, S.; Battistella, L.; Hajiran, C.J.; Sooter, L.J. In vitro selection of a single-stranded DNA molecular recognition element specific for bromacil. J. Nucleic Acids 2014, 2014, 8.
23. Williams, R.M.; Maher, E.; Sooter, L.J. In vitro selection of a single-stranded DNA molecular recognition element for the pesticide malathion. Comb. Chem. High Throughput Screen. 2014, 17, 694-702.
24. Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003, 31, 3406-3415.
25. Gopinath, S.C.; Hayashi, K.; Kumar, P.K. Aptamer that binds to the gD protein of herpes simplex virus 1 and efficiently inhibits viral entry. J. Virol. 2012, 86, 6732-6744.
26. Imaizumi, Y.; Kasahara, Y.; Fujita, H.; Kitadume, S.; Ozaki, H.; Endoh, T.; Kuwahara, M.; Sugimoto, N. Efficacy of base-modification on target binding of small molecule DNA aptamers. J. Am. Chem. Soc. 2013, 135, 9412-9419.
27. Karlsson, R.; Katsamba, P.S.; Nordin, H.; Pol, E.; Myszka, D.G. Analyzing a kinetic titration series using affinity biosensors. Anal. Biochem. 2006, 349, 136-147.
28. Suenaga, E.; Mizuno, H.; Penmetcha, K.K. Monitoring influenza hemagglutinin and glycan interactions using surface plasmon resonance. Biosens. Bioelectron. 2012, 32, 195-201.
29. Ashley, J.; Li, S.F. An aptamer based surface plasmon resonance biosensor for the detection of bovine catalase in milk. Biosens. Bioelectron. 2013, 48, 126-131.
30. Lee, S.J.; Youn, B.S.; Park, J.W.; Niazi, J.H.; Kim, Y.S.; Gu, M.B. ssDNA aptamer-based surface plasmon resonance biosensor for the detection of retinol binding protein 4 for the early diagnosis of type 2 diabetes. Anal. Chem. 2008, 80, 2867-2873.
31. Tran, D.T.; Knez, K.; Janssen, K.P.; Pollet, J.; Spasic, D.; Lammertyn, J. Selection of aptamers against Ara h 1 protein for FO-SPR biosensing of peanut allergens in food matrices. Biosens. Bioelectron. 2013, 43, 245-51.
32. Cella, L.N.; Sanchez, P.; Zhong, W.; Myung, N.V.; Chen, W.; Mulchandani, A. Nano aptasensor for protective antigen toxin of anthrax. Anal. Chem. 2010, 82, 2042-2047.
33. Choi, J.S.; Kim, S.G.; Lahousse, M.; Park, H.Y.; Park, H.C.; Jeong, B.; Kim, J.; Kim, S.K.; Yoon, M.Y. Screening and characterization of high-affinity ssDNA aptamers against anthrax protective antigen. J. Biomol. Screen. 2011, 16, 266-271.
34. Huang, Y.; Chen, X.; Duan, N.; Wu, S.; Wang, Z.; Wei, X.; Wang, Y. Selection and characterization of DNA aptamers against Staphylococcus aureus enterotoxin C1. Food Chem. 2015, 166, 623-629.
35. White, R.R.; Sullenger, B.A.; Rusconi, C.P. Developing aptamers into therapeutics. J. Clin. Investig. 2000, 106, 929-934.
36. Patel, D.J.; Suri, A.K.; Jiang, F.; Jiang, L.; Fan, P.; Kumar, R.A.; Nonin, S. Structure, recognition and adaptive binding in RNA aptamer complexes. J. Mol. Biol. 1997, 272, 645-664.
37. Dayton, S.; Hashimoto, S.; Dixon, W.; Pearce, M.L. Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. J. Lipid Res. 1966, 7, 103-111.
38. Park, J.W.; Kallempudi, S.S.; Niazi, J.H.; Gurbuz, Y.; Youn, B.S.; Gu, M.B. Rapid and sensitive detection of Nampt (PBEF/visfatin) in human serum using an ssDNA aptamer-based capacitive biosensor. Biosens. Bioelectron. 2012, 38, 233-238.
39. Bruno, J.G.; Kiel, J.L. Use of magnetic beads in selection and detection of biotoxin aptamers by electrochemiluminescence and enzymatic methods. Biotechniques 2002, 32, 178-180, 182-183.
40. Mairpady Shambat, S.; Haggar, A.; Vandenesch, F.; Lina, G.; van Wamel, W.J.; Arakere, G.; Svensson, M.; Norrby-Teglund, A. Levels of alpha-toxin correlate with distinct phenotypic response profiles of blood mononuclear cells and with agr background of community-associated Staphylococcus aureus isolates. PLoS One 2014, 9, e106107.
41. Wang, R.E.; Wu, H.; Niu, Y.; Cai, J. Improving the stability of aptamers by chemical modification. Curr. Med. Chem. 2011, 18, 4126-4138.
42. You, K.; Lee, S.; Im, A.; Lee, S. Aptamers as functional nucleic acids: In vitro selection and biotechnological applications. Biotechnol. Bioprocess Eng. 2003, 8, 64-75.
43. Vivekananda, J.; Salgado, C.; Millenbaugh, N.J. DNA aptamers as a novel approach to neutralize Staphylococcus aureus alpha-toxin. Biochem. Biophys. Res. Commun. 2014, 444, 433-438.
44. Tanaka, Y.; Hirano, N.; Kaneko, J.; Kamio, Y.; Yao, M.; Tanaka, I. 2-Methyl-2,4-pentanediol induces spontaneous assembly of staphylococcal alpha-hemolysin into heptameric pore structure. Protein Sci. 2011, 20, 448-456.
45. Wedekind, J.E.; Trame, C.B.; Dorywalska, M.; Koehl, P.; Raschke, T.M.; McKee, M.; FitzGerald, D.; Collier, R.J.; McKay, D.B. Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity. J. Mol. Biol. 2001, 314, 823-837.
46. Bujacz, A. Structures of bovine, equine and leporine serum albumin. Acta Crystallogr. Sect. D 2012, 68, 1278-1289.
47. O’Neal, C.J.; Jobling, M.G.; Holmes, R.K.; Hol, W.G. Structural basis for the activation of cholera toxin by human ARF6-GTP. Science 2005, 309, 1093-1096.
48. Reinert, D.J.; Jank, T.; Aktories, K.; Schulz, G.E. Structural basis for the function of Clostridium difficile toxin B. J. Mol. Biol. 2005, 351, 973-981